CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced the extension of the expiration date of...